Cargando…
Priming therapy by targeting enhancer-initiated pathways in patient-derived pancreatic cancer cells
BACKGROUND: Systems biology leveraging multi-OMICs technologies, is rapidly advancing development of precision therapies and matching patients to targeted therapies, leading to improved responses. A new pillar of precision oncology lies in the power of chemogenomics to discover drugs that sensitizes...
Autores principales: | Fraunhoffer, Nicolas A., Moreno Vega, Aura I., Abuelafia, Analía Meilerman, Morvan, Marie, Lebarbier, Emilie, Mary-Huard, Tristan, Zimmermann, Michael, Lomberk, Gwen, Urrutia, Raul, Dusetti, Nelson, Blum, Yuna, Nicolle, Remy, Iovanna, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189188/ https://www.ncbi.nlm.nih.gov/pubmed/37148583 http://dx.doi.org/10.1016/j.ebiom.2023.104602 |
Ejemplares similares
-
Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction
por: Fraunhoffer, Nicolas A., et al.
Publicado: (2022) -
Limitation and challenges in using pancreatic cancer‐derived organoids as a preclinical tool
por: Fraunhoffer, Nicolas A., et al.
Publicado: (2022) -
Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity
por: Fraunhoffer, Nicolas Alejandro, et al.
Publicado: (2022) -
Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine
por: Lomberk, Gwen, et al.
Publicado: (2019) -
Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance
por: Kaoutari, Abdessamad El, et al.
Publicado: (2021)